Key Points
-
Signal transduction pathways are prime candidates for microRNA (miRNA)-mediated regulation: the highly dynamic and dose-sensitive signalling complexes are the ideal targets for the degree of quantitative regulation imposed by miRNAs.
-
Each cell type expresses a unique set of miRNAs, allowing it to interpret the extracellular signals according to its history and environment, leading to the activation of genes that better suit its needs: a process called context-dependent gene expression.
-
Some signalling pathways are kept actively repressed in the absence of stimulation. This default repression mechanism ensures that target genes are activated only in the presence of a signal. miRNAs contribute to this control, inhibiting the expression of transcripts that are either leaky from transcriptional control or that must be expressed at low levels.
-
A miRNA can be regulated by a signalling pathway and, in turn, target a component of another pathway: in doing so, the miRNA can serve as a mediator of crosstalk between signalling pathways, coordinating their activity.
-
miRNAs are part of signalling networks. By buffering environmental and genetic fluctuations, they confer robustness to the cellular response to extracellular signals.
-
Signalling pathways can control the biogenesis of specific miRNAs at the level of processing. Signalling mediators have been shown to be part of miRNA-processing complexes, tuning miRNA maturation.
Abstract
MicroRNAs (miRNAs) are integral elements in the post-transcriptional control of gene expression. After the identification of hundreds of miRNAs, the challenge is now to understand their specific biological function. Signalling pathways are ideal candidates for miRNA-mediated regulation owing to the sharp dose-sensitive nature of their effects. Indeed, emerging evidence suggests that miRNAs affect the responsiveness of cells to signalling molecules such as transforming growth factor-β, WNT, Notch and epidermal growth factor. As such, miRNAs serve as nodes of signalling networks that ensure homeostasis and regulate cancer, metastasis, fibrosis and stem cell biology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lee, R. C., Feinbaum, R. L. & Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843–854 (1993).
Wightman, B., Ha, I. & Ruvkun, G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75, 855–862 (1993).
Reinhart, B. J. et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901–906 (2000).
Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233 (2009).
Bartel, D. P. & Chen, C. Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nature Rev. Genet. 5, 396–400 (2004).
Carthew, R. W. & Sontheimer, E. J. Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642–655 (2009).
Brodersen, P. & Voinnet, O. Revisiting the principles of microRNA target recognition and mode of action. Nature Rev. Mol. Cell Biol. 10, 141–148 (2009).
Kim, V. N., Han, J. & Siomi, M. C. Biogenesis of small RNAs in animals. Nature Rev. Mol. Cell Biol. 10, 126–139 (2009).
Baek, D. et al. The impact of microRNAs on protein output. Nature 455, 64–71 (2008).
Lindsley, D. L. et al. Segmental aneuploidy and the genetic gross structure of the Drosophila genome. Genetics 71, 157–184 (1972).
Leaman, D. et al. Antisense-mediated depletion reveals essential and specific functions of microRNAs in Drosophila development. Cell 121, 1097–1108 (2005).
Li, X. & Carthew, R. W. A microRNA mediates EGF receptor signaling and promotes photoreceptor differentiation in the Drosophila eye. Cell 123, 1267–1277 (2005).
Li, X., Cassidy, J. J., Reinke, C. A., Fischboeck, S. & Carthew, R. W. A microRNA imparts robustness against environmental fluctuation during development. Cell 137, 273–282 (2009). This paper suggests that some conserved miRNAs, such as miR-7, can enter into new genetic relationships to buffer developmental programmes against variation and impart robustness to diverse regulatory signaling networks.
Miska, E. A. et al. Most Caenorhabditis elegans microRNAs are individually not essential for development or viability. PLoS Genet. 3, e215 (2007).
Thai, T. H. et al. Regulation of the germinal center response by microRNA-155. Science 316, 604–608 (2007).
Xiao, C. et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131, 146–159 (2007).
Murchison, E. P., Partridge, J. F., Tam, O. H., Cheloufi, S. & Hannon, G. J. Characterization of Dicer-deficient murine embryonic stem cells. Proc. Natl Acad. Sci. USA 102, 12135–12140 (2005).
Tang, F. et al. Maternal microRNAs are essential for mouse zygotic development. Genes Dev. 21, 644–648 (2007).
Yi, R., Poy, M. N., Stoffel, M. & Fuchs, E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 452, 225–229 (2008).
Tsang, J., Zhu, J. & van Oudenaarden, A. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol. Cell 26, 753–767 (2007).
De Robertis, E. M., Larrain, J., Oelgeschlager, M. & Wessely, O. The establishment of Spemann's organizer and patterning of the vertebrate embryo. Nature Rev. Genet. 1, 171–181 (2000).
Harvey, K. & Tapon, N. The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network. Nature Rev. Cancer 7, 182–191 (2007).
Niehrs, C. Regionally specific induction by the Spemann–Mangold organizer. Nature Rev. Genet. 5, 425–434 (2004).
Chen, K. & Rajewsky, N. The evolution of gene regulation by transcription factors and microRNAs. Nature Rev. Genet. 8, 93–103 (2007).
Davidson, E. H. & Erwin, D. H. Gene regulatory networks and the evolution of animal body plans. Science 311, 796–800 (2006).
Heimberg, A. M., Sempere, L. F., Moy, V. N., Donoghue, P. C. & Peterson, K. J. MicroRNAs and the advent of vertebrate morphological complexity. Proc. Natl Acad. Sci. USA 105, 2946–2950 (2008).
Sempere, L. F., Cole, C. N., McPeek, M. A. & Peterson, K. J. The phylogenetic distribution of metazoan microRNAs: insights into evolutionary complexity and constraint. J. Exp. Zool. B Mol. Dev. Evol. 306, 575–588 (2006).
Clevers, H. Wnt/β-catenin signaling in development and disease. Cell 127, 469–480 (2006).
Jiang, J. & Hui, C. C. Hedgehog signaling in development and cancer. Dev. Cell 15, 801–812 (2008).
Kopan, R. & Ilagan, M. X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216–233 (2009).
Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 103, 211–225 (2000).
Schmierer, B. & Hill, C. S. TGFβ–SMAD signal transduction: molecular specificity and functional flexibility. Nature Rev. Mol. Cell Biol. 8, 970–982 (2007).
Barolo, S. & Posakony, J. W. Three habits of highly effective signaling pathways: principles of transcriptional control by developmental cell signaling. Genes Dev. 16, 1167–1181 (2002).
Kennell, J. A., Gerin, I., MacDougald, O. A. & Cadigan, K. M. The microRNA miR-8 is a conserved negative regulator of Wnt signaling. Proc. Natl Acad. Sci. USA 105, 15417–15422 (2008).
Ferretti, E. et al. Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J. 27, 2616–2627 (2008).
Hornstein, E. & Shomron, N. Canalization of development by microRNAs. Nature Genet. 38, S20–S24 (2006). This review discusses how miRNAs act as players in gene networks to confer robustness to developmental processes.
Lai, E. C., Tam, B. & Rubin, G. M. Pervasive regulation of Drosophila Notch target genes by GY-box-, Brd-box-, and K-box-class microRNAs. Genes Dev. 19, 1067–1080 (2005).
Lai, E. C., Burks, C. & Posakony, J. W. The K box, a conserved 3′ UTR sequence motif, negatively regulates accumulation of enhancer of split complex transcripts. Development 125, 4077–4088 (1998).
Lai, E. C. & Posakony, J. W. The Bearded box, a novel 3′ UTR sequence motif, mediates negative post-transcriptional regulation of Bearded and Enhancer of split complex gene expression. Development 124, 4847–4856 (1997).
Junttila, M. R. & Evan, G. I. p53 — a Jack of all trades but master of none. Nature Rev. Cancer 9, 821–829 (2009).
Le, M. T. et al. MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 23, 862–876 (2009).
Teleman, A. A., Maitra, S. & Cohen, S. M. Drosophila lacking microRNA miR-278 are defective in energy homeostasis. Genes Dev. 20, 417–422 (2006).
Voorhoeve, P. M. et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124, 1169–1181 (2006).
Nairz, K. et al. Overgrowth caused by misexpression of a microRNA with dispensable wild-type function. Dev. Biol. 291, 314–324 (2006).
Nolo, R., Morrison, C. M., Tao, C., Zhang, X. & Halder, G. The bantam microRNA is a target of the hippo tumor-suppressor pathway. Curr. Biol. 16, 1895–1904 (2006).
Thompson, B. J. & Cohen, S. M. The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell 126, 767–774 (2006).
Gurdon, J. B. From nuclear transfer to nuclear reprogramming: the reversal of cell differentiation. Annu. Rev. Cell Dev. Biol. 22, 1–22 (2006).
Martello, G. et al. MicroRNA control of Nodal signalling. Nature 449, 183–188 (2007).
Choi, W. Y., Giraldez, A. J. & Schier, A. F. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 318, 271–274 (2007). This paper reveals a requirement for a miRNA in dampening and balancing agonist–antagonist pairs.
Rogler, C. E. et al. MicroRNA-23b cluster microRNAs regulate transforming growth factor-β/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology 50, 575–584 (2009).
Pasquinelli, A. E. et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408, 86–89 (2000).
Bussing, I., Slack, F. J. & Grosshans, H. let-7 microRNAs in development, stem cells and cancer. Trends Mol. Med. 14, 400–409 (2008).
Peter, M. E. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8, 843–852 (2009).
Johnson, S. M. et al. RAS is regulated by the let-7 microRNA family. Cell 120, 635–647 (2005). This paper shows that the let-7 miRNA family negatively regulates RAS levels during terminal differentiation of C. elegans and tumour formation in humans.
Yu, F. et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109–1123 (2007).
Nishino, J., Kim, I., Chada, K. & Morrison, S. J. Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression. Cell 135, 227–239 (2008).
Cully, M., You, H., Levine, A. J. & Mak, T. W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nature Rev. Cancer 6, 184–192 (2006).
Di Cristofano, A. & Pandolfi, P. P. The multiple roles of PTEN in tumor suppression. Cell 100, 387–390 (2000).
Ueki, K. et al. Positive and negative roles of p85 α and p85 β regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J. Biol. Chem. 278, 48453–48466 (2003).
Wakioka, T. et al. Spred is a Sprouty-related suppressor of Ras signalling. Nature 412, 647–651 (2001).
Fish, J. E. et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15, 272–284 (2008).
Kuhnert, F. et al. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135, 3989–3993 (2008).
Meng, F. et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647–658 (2007).
Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980–984 (2008).
Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA 103, 2257–2261 (2006).
Huse, J. T. et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 23, 1327–1337 (2009).
Kato, M. et al. TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nature Cell Biol. 11, 881–889 (2009). This study reveals a mechanism of Akt activation through PTEN downregulation by two miRNAs that are regulated by upstream miR-192 and TGFβ.
Blanpain, C. & Fuchs, E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nature Rev. Mol. Cell Biol. 10, 207–217 (2009).
Senoo, M., Pinto, F., Crum, C. P. & McKeon, F. p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129, 523–536 (2007).
Thatcher, E. J., Paydar, I., Anderson, K. K. & Patton, J. G. Regulation of zebrafish fin regeneration by microRNAs. Proc. Natl Acad. Sci. USA 105, 18384–18389 (2008).
Alon, U. Network motifs: theory and experimental approaches. Nature Rev. Genet. 8, 450–461 (2007).
Martinez, N. J. et al. A C. elegans genome-scale microRNA network contains composite feedback motifs with high flux capacity. Genes Dev. 22, 2535–2549 (2008).
Ozsolak, F., Song, J. S., Liu, X. S. & Fisher, D. E. High-throughput mapping of the chromatin structure of human promoters. Nature Biotechnol. 25, 244–248 (2007).
Stark, A., Brennecke, J., Bushati, N., Russell, R. B. & Cohen, S. M. Animal microRNAs confer robustness to gene expression and have a significant impact on 3′UTR evolution. Cell 123, 1133–1146 (2005).
Shkumatava, A., Stark, A., Sive, H. & Bartel, D. P. Coherent but overlapping expression of microRNAs and their targets during vertebrate development. Genes Dev. 23, 466–481 (2009).
Yu, J. & Thomson, J. A. Pluripotent stem cell lines. Genes Dev. 22, 1987–1997 (2008).
Marson, A. et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134, 521–533 (2008).
Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834–838 (2005).
Ventura, A. & Jacks, T. MicroRNAs and cancer: short RNAs go a long way. Cell 136, 586–591 (2009).
Kumar, M. S., Lu, J., Mercer, K. L., Golub, T. R. & Jacks, T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nature Genet. 39, 673–677 (2007).
Kumar, M. S. et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev. 23, 2700–2704 (2009).
Gupta, G. P. & Massague, J. Cancer metastasis: building a framework. Cell 127, 679–695 (2006).
Polyak, K. & Weinberg, R. A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Rev. Cancer 9, 265–273 (2009).
Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature Cell Biol. 10, 593–601 (2008).
Bracken, C. P. et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 68, 7846–7854 (2008).
Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715 (2008).
Xu, N., Papagiannakopoulos, T., Pan, G., Thomson, J. A. & Kosik, K. S. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137, 647–658 (2009).
Ozsolak, F. et al. Chromatin structure analyses identify miRNA promoters. Genes Dev. 22, 3172–3183 (2008).
Morlando, M. et al. Primary microRNA transcripts are processed co-transcriptionally. Nature Struct. Mol. Biol. 15, 902–909 (2008).
Thomson, J. M. et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20, 2202–2207 (2006).
Viswanathan, S. R., Daley, G. Q. & Gregory, R. I. Selective blockade of microRNA processing by Lin28. Science 320, 97–100 (2008).
Heo, I. et al. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 138, 696–708 (2009).
Suzuki, H. I. et al. Modulation of microRNA processing by p53. Nature 460, 529–533 (2009). This paper reveals a previously unrecognized function of p53 in miRNA processing, which may underlie key aspects of cancer biology.
Adorno, M. et al. A Mutant-p53/Smad complex opposes p63 to empower TGFβ-induced metastasis. Cell 137, 87–98 (2009).
Davis, B. N., Hilyard, A. C., Lagna, G. & Hata, A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454, 56–61 (2008).
Silver, S. J., Hagen, J. W., Okamura, K., Perrimon, N. & Lai, E. C. Functional screening identifies miR-315 as a potent activator of Wingless signaling. Proc. Natl Acad. Sci. USA 104, 18151–18156 (2007).
Krutzfeldt, J. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685–689 (2005).
Lanford, R. E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198–201 (2010).
Croce, C. M. Causes and consequences of microRNA dysregulation in cancer. Nature Rev. Genet. 10, 704–714 (2009).
Stefani, G. & Slack, F. J. Small non-coding RNAs in animal development. Nature Rev. Mol. Cell Biol. 9, 219–230 (2008).
Lee, Y. S. et al. Silencing by small RNAs is linked to endosomal trafficking. Nature Cell Biol. 11, 1150–1156 (2009).
Gibbings, D. J., Ciaudo, C., Erhardt, M. & Voinnet, O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nature Cell Biol. 11, 1143–1149 (2009).
Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biol. 9, 654–659 (2007).
Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Rev. Genet. 9, 102–114 (2008).
Acknowledgements
We thank the members of the S.P. laboratory for thoughtful insights. We apologize to those whose work could not be cited owing to space limitations. We thank O. Wessely for comments and insights on the manuscript. Our miRNA work is supported by grants from Associazione Italiana Ricerca sul Cancro (AIRC), Comitato Promotere Telethon, Cariparo Foundation (excellence grant), University of Padua (strategic grant) to S.P., by the Ministery of Health (Giovani Ricercatori) to G.M. and by a Uehara Foundation and Marie Curie International fellowship to M.I.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Glossary
- Haploinsufficient
-
A gene that requires biallelic expression. Suppression of one allele would reduce the gene dosage below the crucial level.
- Cerebellar granule progenitor cell
-
A cell that is located in the outermost layer of the cerebellar cortex in newborns and that generates the most abundant type of neuron of the mammalian brain.
- Medulloblastoma
-
A highly malignant primary brain tumour that originates in the cerebellum.
- Hypomorphic
-
A mutation that reduces, but does not completely eliminate, the function of a gene.
- Spemann's organizer
-
The portion of the amphibian embryo (dorsal blastopore lip, corresponding to the node of mammalian and avian embryos) endowed with the capacity to induce a secondary body after transplantation into a host embryo.
- Gliomagenesis
-
Emergence of a tumour that arises from glial cells in the brain or spinal cord.
- Glomerular mesangial cell
-
A component of the renal glomerulus that can contract and relax and secrete inflammatory cytokines.
- Basal layer
-
The deepest layer of pluristratified epithelia, which are attached to the basement membrane and enriched in stem or transient amplifying progenitor cells.
- Suprabasal
-
The layer of cells in mammalian epithelia that are located just above the deepest (or basal) layer, typically generated by the asymmetric cell division of basally located stem cells.
- Nucleosome
-
The fundamental packing unit of the eukaryotic chromatin, consisting of DNA wrapped around the histone octamer.
- Uridylation
-
Enzymatic reaction leading to the addition of uridine nucleoside to the 3′ end of a miRNA strand.
- AntagomiR and locked nucleic acid
-
Chemically engineered synthetic oligonucleotides that are complementary to the specific miRNA target, with modifications to make it more resistant to degradation to optimize silencing of endogenous miRNAs.
- Multivesicular body
-
An endocytic intermediate organelle in the lysosomal degradative pathway that contains small vesicles and is surrounded by a limiting membrane.
- Exosome
-
A small vesicle that is secreted by a wide range of cell types and that consists of a lipid raft embedded with components of the original cell membrane that can be shuttled to a different cell.
Rights and permissions
About this article
Cite this article
Inui, M., Martello, G. & Piccolo, S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11, 252–263 (2010). https://doi.org/10.1038/nrm2868
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrm2868
This article is cited by
-
Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease
Cellular & Molecular Biology Letters (2024)
-
The impact of substrate stiffness on morphological, transcriptional and functional aspects in RPE
Scientific Reports (2024)
-
E2F5 Targeted by Let-7d-5p Facilitates Cell Proliferation, Metastasis and Immune Escape in Gallbladder Cancer
Digestive Diseases and Sciences (2024)
-
CD204-positive M2-like tumor-associated macrophages increase migration of gastric cancer cells by upregulating miR-210 to reduce NTN4 expression
Cancer Immunology, Immunotherapy (2024)
-
MiRNA-93: a novel signature in human disorders and drug resistance
Cell Communication and Signaling (2023)